File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.3748/wjg.v20.i46.17448
- Scopus: eid_2-s2.0-84918526455
- PMID: 25516657
- WOS: WOS:000346386300021
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability
Title | Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability |
---|---|
Authors | |
Keywords | Adjuvant therapy Head of pancreas Liver transplant Morbidity Mortality Portal vein resection Survival analysis Whipple operation |
Issue Date | 2014 |
Citation | World Journal of Gastroenterology, 2014, v. 20 n. 46, p. 17448-17455 How to Cite? |
Abstract | AIM: To analyze whether pancreaticoduodenectomy with simultaneous resection of tumor-involved vessels is a safe approach with acceptable patient survival.
METHODS: Between January 2001 and March 2012, 136 patients received pancreaticoduodenectomy for adenocarcinoma at our hospital. Seventy-eight patients diagnosed with pancreatic head carcinoma were included in this study. Among them, 46 patients received standard pancreaticoduodenectomy (group 1) and 32 patients received pancreaticoduodenectomy with simultaneous resection of the portal vein or the superior mesenteric vein or artery (group 2) followed by reconstruction. The immediate surgical outcomes and survivals were compared between the groups. Fifty-five patients with unresectable adenocarcinoma of the pancreas without liver metastasis who received only bypass operations (group 3) were selected for additional survival comparison.
RESULTS: The median ages of patients were 67 years (range: 37-82 years) in group 1, and 63 years (range: 35-86 years) in group 2. All group 2 patients had resection of the portal vein or the superior mesenteric vein and three patients had resection of the superior mes-enteric artery. The pancreatic fistula formation rate was 21.7% (10/46) in group 1 and 15.6% (5/32) in group 2 (P = 0.662). Two hospital deaths (4.3%) occurred in group 1 and one hospital death (3.1%) occurred in group 2 (P = 0.641). The one-year, three-year and five-year overall survival rates in group 1 were 71.1%, 23.6% and 13.5%, respectively. The corresponding rates in group 2 were 70.6%, 33.3% and 22.2% (P = 0.815). The one-year survival rate in group 3 was 13.8%. Pancreaticoduodenectomy with simultaneous vascular resection was safe for pancreatic head adenocarcinoma.
CONCLUSION: The short-term and survival outcomes with simultaneous resection were not compromised when compared with that of standard pancreaticoduodenectomy. © 2014 Baishideng Publishing Group Inc. All rights reserved. |
Persistent Identifier | http://hdl.handle.net/10722/218909 |
ISSN | 2023 Impact Factor: 4.3 2023 SCImago Journal Rankings: 1.063 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cheung, TT | - |
dc.contributor.author | Poon, RTP | - |
dc.contributor.author | Chok, KSH | - |
dc.contributor.author | Chan, ACY | - |
dc.contributor.author | Tsang, HYS | - |
dc.contributor.author | Dai, WC | - |
dc.contributor.author | Chan, SC | - |
dc.contributor.author | Fan, ST | - |
dc.contributor.author | Lo, CM | - |
dc.date.accessioned | 2015-09-18T07:00:38Z | - |
dc.date.available | 2015-09-18T07:00:38Z | - |
dc.date.issued | 2014 | - |
dc.identifier.citation | World Journal of Gastroenterology, 2014, v. 20 n. 46, p. 17448-17455 | - |
dc.identifier.issn | 1007-9327 | - |
dc.identifier.uri | http://hdl.handle.net/10722/218909 | - |
dc.description.abstract | AIM: To analyze whether pancreaticoduodenectomy with simultaneous resection of tumor-involved vessels is a safe approach with acceptable patient survival. METHODS: Between January 2001 and March 2012, 136 patients received pancreaticoduodenectomy for adenocarcinoma at our hospital. Seventy-eight patients diagnosed with pancreatic head carcinoma were included in this study. Among them, 46 patients received standard pancreaticoduodenectomy (group 1) and 32 patients received pancreaticoduodenectomy with simultaneous resection of the portal vein or the superior mesenteric vein or artery (group 2) followed by reconstruction. The immediate surgical outcomes and survivals were compared between the groups. Fifty-five patients with unresectable adenocarcinoma of the pancreas without liver metastasis who received only bypass operations (group 3) were selected for additional survival comparison. RESULTS: The median ages of patients were 67 years (range: 37-82 years) in group 1, and 63 years (range: 35-86 years) in group 2. All group 2 patients had resection of the portal vein or the superior mesenteric vein and three patients had resection of the superior mes-enteric artery. The pancreatic fistula formation rate was 21.7% (10/46) in group 1 and 15.6% (5/32) in group 2 (P = 0.662). Two hospital deaths (4.3%) occurred in group 1 and one hospital death (3.1%) occurred in group 2 (P = 0.641). The one-year, three-year and five-year overall survival rates in group 1 were 71.1%, 23.6% and 13.5%, respectively. The corresponding rates in group 2 were 70.6%, 33.3% and 22.2% (P = 0.815). The one-year survival rate in group 3 was 13.8%. Pancreaticoduodenectomy with simultaneous vascular resection was safe for pancreatic head adenocarcinoma. CONCLUSION: The short-term and survival outcomes with simultaneous resection were not compromised when compared with that of standard pancreaticoduodenectomy. © 2014 Baishideng Publishing Group Inc. All rights reserved. | - |
dc.language | eng | - |
dc.relation.ispartof | World Journal of Gastroenterology | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Adjuvant therapy | - |
dc.subject | Head of pancreas | - |
dc.subject | Liver transplant | - |
dc.subject | Morbidity | - |
dc.subject | Mortality | - |
dc.subject | Portal vein resection | - |
dc.subject | Survival analysis | - |
dc.subject | Whipple operation | - |
dc.title | Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability | - |
dc.type | Article | - |
dc.identifier.email | Cheung, TT: cheung68@hku.hk | - |
dc.identifier.email | Poon, RTP: poontp@hku.hk | - |
dc.identifier.email | Chok, KSH: chok6275@hku.hk | - |
dc.identifier.email | Chan, ACY: acchan@hku.hk | - |
dc.identifier.email | Dai, WC: daiwc@hku.hk | - |
dc.identifier.email | Chan, SC: chanlsc@hkucc.hku.hk | - |
dc.identifier.email | Fan, ST: stfan@hku.hk | - |
dc.identifier.email | Lo, CM: chungmlo@hkucc.hku.hk | - |
dc.identifier.authority | Poon, RTP=rp00446 | - |
dc.identifier.authority | Chan, ACY=rp00310 | - |
dc.identifier.authority | Chan, SC=rp01568 | - |
dc.identifier.authority | Fan, ST=rp00355 | - |
dc.identifier.authority | Lo, CM=rp00412 | - |
dc.description.nature | published_or_final_version | - |
dc.identifier.doi | 10.3748/wjg.v20.i46.17448 | - |
dc.identifier.pmid | 25516657 | - |
dc.identifier.scopus | eid_2-s2.0-84918526455 | - |
dc.identifier.hkuros | 253543 | - |
dc.identifier.volume | 20 | - |
dc.identifier.issue | 46 | - |
dc.identifier.spage | 17448 | - |
dc.identifier.epage | 17455 | - |
dc.identifier.isi | WOS:000346386300021 | - |
dc.identifier.issnl | 1007-9327 | - |